
Pardes Biosciences
Pardes Biosciences is a YC Summer 2020 (S20) company. Based in San Francisco, CA, USA; Remote. Team of 2.
About Pardes Biosciences
Summary
Pardes Biosciences develops oral antiviral drugs to treat and prevent viral infections, including COVID-19. The company focuses on small-molecule therapeutics that patients can take by mouth, replacing or supplementing injectable or hospital-administered antiviral options.
From the Y Combinator listing
We break viruses
We make oral drugs to treat and prevent viral infections - like COVID-19.
Facts
- Healthcare / Healthcare -> Drug Discovery and Delivery
- San Francisco, CA, USA; Remote
- 2
- Public
- Early
Founders (1)
- Uri Lopatin
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works